Characterization of Hepatic and Intestinal Glucuronidation of Magnolol: Application of the Relative Activity Factor Approach to Decipher the Contributions of Multiple UDP-Glucuronosyltransferase Isoforms
文献类型:期刊论文
作者 | Zhu, Liangliang1,2; Ge, Guangbo1; Zhang, Hongbo3; Liu, Huixin1; He, Guiyuan1,2; Liang, Sicheng1; Zhang, Yanyan1; Fang, Zhongze1; Dong, Peipei1; Finel, Moshe3 |
刊名 | drug metabolism and disposition
![]() |
出版日期 | 2012-03-01 |
卷号 | 40期号:3页码:529-538 |
产权排序 | 1,1 |
通讯作者 | 杨凌 |
英文摘要 | magnolol is a food additive that is often found in mints and gums. human exposure to this compound can reach a high dose; thus, characterization of magnolol disposition in humans is very important. previous studies indicated that magnolol can undergo extensive glucuronidation in humans in vivo. in this study, in vitro assays were used to characterize the glucuronidation pathway in human liver and intestine. assays with recombinant human udp-glucuronosyltransferase enzymes (ugts) revealed that multiple ugt isoforms were involved in magnolol glucuronidation, including ugt1a1, -1a3, -1a7, -1a8, -1a9, -1a10, and -2b7. magnolol glucuronidation by human liver microsomes (hlm), human intestine microsomes (him), and most recombinant ugts exhibited strong substrate inhibition kinetics. the degree of substrate inhibition was relatively low in the case of ugt1a10, whereas the reaction catalyzed by ugt1a9 followed biphasic kinetics. chemical inhibition studies and the relative activity factor (raf) approach were used to identify the individual ugts that played important roles in magnolol glucuronidation in hlm and him. the results indicate that ugt2b7 is mainly responsible for the reaction in hlm, whereas ugt2b7 and ugt1a10 are significant contributors in him. in summary, the current study clarifies the glucuronidation pathway of magnolol and demonstrates that the raf approach can be used as an efficient method for deciphering the roles of individual ugts in a given glucuronidation pathway in the native tissue that is catalyzed by multiple isoforms with variable and atypical kinetics. |
WOS标题词 | science & technology ; life sciences & biomedicine |
学科主题 | 物理化学 |
类目[WOS] | pharmacology & pharmacy |
研究领域[WOS] | pharmacology & pharmacy |
关键词[WOS] | human liver-microsomes ; drug-glucuronidation ; substrate ; expression ; cytochrome-p450 ; specificity ; selectivity ; metabolism ; dopamine ; kinetics |
收录类别 | SCI |
语种 | 英语 |
WOS记录号 | WOS:000300610100017 |
公开日期 | 2013-10-11 |
源URL | [http://159.226.238.44/handle/321008/118375] ![]() |
专题 | 大连化学物理研究所_中国科学院大连化学物理研究所 |
作者单位 | 1.Chinese Acad Sci, Lab Pharmaceut Resource Discovery, Dalian Inst Chem Phys, Dalian 116023, Peoples R China 2.Chinese Acad Sci, Grad Univ, Beijing, Peoples R China 3.Univ Helsinki, Ctr Drug Res, Fac Pharm, Helsinki, Finland |
推荐引用方式 GB/T 7714 | Zhu, Liangliang,Ge, Guangbo,Zhang, Hongbo,et al. Characterization of Hepatic and Intestinal Glucuronidation of Magnolol: Application of the Relative Activity Factor Approach to Decipher the Contributions of Multiple UDP-Glucuronosyltransferase Isoforms[J]. drug metabolism and disposition,2012,40(3):529-538. |
APA | Zhu, Liangliang.,Ge, Guangbo.,Zhang, Hongbo.,Liu, Huixin.,He, Guiyuan.,...&Yang, Ling.(2012).Characterization of Hepatic and Intestinal Glucuronidation of Magnolol: Application of the Relative Activity Factor Approach to Decipher the Contributions of Multiple UDP-Glucuronosyltransferase Isoforms.drug metabolism and disposition,40(3),529-538. |
MLA | Zhu, Liangliang,et al."Characterization of Hepatic and Intestinal Glucuronidation of Magnolol: Application of the Relative Activity Factor Approach to Decipher the Contributions of Multiple UDP-Glucuronosyltransferase Isoforms".drug metabolism and disposition 40.3(2012):529-538. |
入库方式: OAI收割
来源:大连化学物理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。